Mainz Biomed: Heiner Dreismann

Heiner Dreismann has been appointed to the strategic advisory board of cancer molecular diagnostics company Mainz Biomed. He is the former president and CEO of Roche Molecular Systems and held other senior positions at Roche, including head of global business development for Roche Diagnostics and member of Roche's global diagnostic executive committee.